PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Milestone Venture Partners invests in IntegriChain

Milestone Venture Partners, an early-stage venture capital firm, has led a series B financing in IntegriChain, a provider of data solutions to the pharmaceutical industry.

Milestone Venture Partners, an early-stage venture capital firm, has led a series B financing in IntegriChain, a provider of data solutions to the pharmaceutical industry.

Milestone was joined in the financing by Cross Atlantic Partners.

As a result of the financing, Morgan Rodd, general partner of Milestone, will join IntegriChain’s board of directors.

New Jersey-based IntegriChain provides the pharmaceutical industry with data collection, integration, enrichment, analysis and reporting of sales and inventory activity.

IntegriChain’s data solutions help customers to improve sales performance and pipeline measurement by maximizing transparency and accountability in each customer’s down-stream supply chain.

The investment in IntegriChain marks the 13th investment that Milestone has made out of its current fund, Milestone Venture Partners III. IntegriChain represents the fifth healthcare technology investment Milestone has made out of its current fund and the ninth healthcare technology investment overall.

‘We invested in IntegriChain because of its explosive growth vector and its outstanding long-term investment potential. Its superior data solutions provide its customers a much more granular and accurate view of what is happening within their supply-chains than other solutions currently in the market,’ says Morgan Rodd, general partner of Milestone.

‘By using IntegriChain’s data solutions, its existing customers can make more effective business decisions within several key areas, including new product launches, finance, sales forecasting and demand analysis, thereby driving operational efficiencies and improving financial performance across a customer’s entire organisation.’

‘We are pleased to have Milestone as an investor and delighted to have Morgan Rodd join our board,’ says Kevin Leininger, chief executive of IntegriChain. ‘We chose to partner with Milestone because of their deep domain expertise in healthcare information technology and their understanding of the healthcare ecosystem. In addition, Milestone has a strong track record of successful investments in the healthcare IT space, and we believe they will add significant value as we continue to build IntegriChain.’

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured